Interações medicamentosas em prescrições médicas em pacientes acometidos pelo coronavírus da síndrome respiratória aguda grave

Keylla Talitha Fernandes Barbosa, Júlia Beatriz Lacet Nóbrega da Silva Lima, Felipe Pereira Nunes, Fabiana Maria Rodrigues Lopes de Oliveira, Gabriela Lisieux Lima Gomes, Natalia Pessoa Rocha Leal

Resumo


Objetivo: Identificar as potenciais interações medicamentosas em prescrições médicas em pacientes acometidos por coronavírus da síndrome respiratória aguda grave. Método: Trata-se de um estudo descritivo, do tipo documental e retrospectivo realizado no período de abril a junho de 2020. Os dados foram coletados por meio de instrumento semi-estruturado, que abordou os medicamentos utilizados, dados sociodemográficos, e condições clínicas associadas. A análise dos dados efetivou-se numa abordagem quantitativa por estatística descritiva. Resultados: Verificou-se que os fármacos mais utilizados foram azitromicina, ondasetrona, enoxaparina e omeprazol. Ao avaliar as possíveis interações medicamentosas, constatou-se a média de 2,98 por cliente, sendo as de maior gravidade a ondasetrona e azitromicina; cloridrato de ondansetrona di-hidratado e fentanil, assim como midazolam e fentanil. Conclusão: Enfatiza-se a necessidade em avaliar os fármacos prescritos, bem como seus aprazamentos de forma que a assistência ao paciente seja realizada com o mínimo de danos.


Texto completo:

PDF

Referências


Nascimento IJB, Cacic N, Abdulazeem HM, Von Groote TC, Jayarajah U, Weerasekara I et al. Novel Coronavirus Infection (COVID-19) in Humans: A Scoping Review and Meta-Analysis. Clin. Med. [Internet]. 2020 [cited 2021 Feb 28];9(4). Available from: https://doi.org/10.3390/jcm9040941.

Croda JHR, Garcia LP. Immediate health surveillance response to COVID-19 epidemic. Epidemiol. Serv. Saúde [Internet]. 2020 [cited 2021 Feb 28];29(1). Available from: https://doi.org/10.5123/s1679-49742020000100021.

Falavigna M, Colpani V, Stein C, Azevedo LCP, Bagattini AM, Brito GV, et al. Guidelines for the pharmacological treatment of COVID-19. The task-force/consensus guideline of the Brazilian Association of Intensive Care Medicine, the Brazilian Society of Infectious Diseases and the Brazilian Society of Pulmonology and Tisiology. Rev. bras. ter. intensiva [Internet]. 2020 [cited 2021 Feb 28]; 32(2). Available from: https://doi.org/10.5935/0103-507x.20200039

Moreira MB, Mesquita MGR, Stipp MAC, Paes GO. Potential intravenous drug interactions in intensive care. Rev. Esc. Enferm. USP [Internet]. 2017 [cited 2021 Feb 28];51:e03233. Available from: http://dx.doi.org/10.1590/S1980-220X2016034803233

Cortes ALB, Silvino ZR, Santos FBM, Pereira JAC, Tavares GS. Prevalência de interações medicamentosas envolvendo medicamentos de alta vigilância: estudo transversal. REME rev. min. enferm. [Internet]. 2019 [cited 2021 Feb 28];23:e-1226. Available from: http://dx.doi.org/10.5935/1415-2762.20190074

Mieiro DB, Oliveira EBC, Fonseca REP, Mininel VA, Mascarenhas SH, Machado RC. Strategies to minimize medication erros in emergency units: na integrative review. Rev. Bras. Enferm [Internet]. 2019 [cited 2021 Feb 28];58(4):399-404. Available from: https://doi.org/10.1590/0034-7167-2017-0658

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet [Internet]. 2020 [cited 2021 Feb 28];395: 507–13. Available from: https://doi.org/10.1016/ S0140-6736(20)30211-7

Souza AR. Como a pandemia por covid-19 pode afetar a saúde de homens? Uma análise sociohistórica. Revista Prevenção de Infecção em Saúde [Internet]. 2020 [cited 2021 Feb 28];6:10549. Available from: https://doi.org/10.26694/repis.v6i0.10549.

Ten-Caten F, Gonzalez-Días P, Castro I, Ogava RLT, Giddaluru J, Silva JCS et al. In-depth Analysis of Laboratory Parameters Reveals the Interplay Between Sex, Age and Systemic Inflammation in Individuals with COVID-19. Int J Infect Dis [Internet]. 2021 [cited 2021 Mar 20];12(21):1-23. Available from: https://doi.org/10.1016/j.ijid.2021.03.016

Neto UEA, Pires AC. Drogas e medicamentos investigados para o tratamento do COVID-19. Rev. De Saúde e Ciências Biológicas [Internet]. 2020 [cited 2021 Feb 28]; 8(1). Available from: http://dx.doi.org/10.12662/2317-3076jhbs.v8i1.3284.p1-7.2020

Bezerra HCB, Xavier DP, Bachur TPR, Aragão GF. Fármacos antimicrobianos e antivirais com potencial uso terapêutico para a covid-19. Infarma [Internet]. 2020 [cited 2021 Feb 28]; 32(2). Available from: https://dx.doi.org/10.14450/2318-9312.v32.e2.a2020.pp109-119

Pani A, Lauriola M, Romandini A, Scaglione F. Macrolides and viral infections: focus on azithromycin in COVID-19 pathology. Int. J. Antimicrob. Agents [Internet]. 2020 [cited 2021 Feb 28];56 (2). Available from: https://doi.org/10.1016/j.ijantimicag.2020.106053

Andrade LM, Coelho JLG, Almeida NS, Luz DCR, Monte EC, Araújo AF, et al. Importance os antibiotics the treatment os Covid-19. Res. Soc. Dev. [Internet]. 2020 [cited 2021 Feb 28]; 9(10). Available from: http://dx.doi.org/10.33448/rsd-v9i10.8481

Recovery Collaborative Group. Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet [Internet]. 2021 [cited 2021 Feb 28]; 397: 605-12. Available from: https://doi.org/10.1016/ S0140-6736(21)00149-5.

Furtado RHM, Berwanger O, Fonseca HÁ, Corrêa TD, Ferraz LR, Lapa MG et al. Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial. Lancet [Internet] 2020 [cited 2021 Feb 28];396: 959–67. Available from: https://doi.org/10.1016/S0140-6736(20)31862-6.

Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L et al. Dexamethasone in hospitalized patients with Covid-19—Preliminary Report. N Engl J Med [Internet] 2020. [cited 2021 Feb 28];384:693-704. Available from: https://doi.org/10.1056/NEJMoa2021436

Sterne JAC, Murthy S, Diaz JV, Slutsky AS, Villar J, Angus DC et al. Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis. JAMA [Internet]. 2020. [cited 2021 Feb 28]; 324(13):1330-1341. Available from: https://doi.org/10.1001/jama.2020.17023

Russell CD, Millar JE, Baillie JK. Clinical evidence does not support corticosteroid treatment for 2019- nCoV lung injury. Lancet [Internet]. 2020 [cited 2021 Feb 28];395(15). Available from: https://doi.org/10.1016/S0140-6736(20)30317-2

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong YJJ. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. Jama [Internet]. 2020 [cited 2021 Feb 28];323 (11):1061-1069. Available from: https://doi:10.1001/jama.2020.1585

Hernandez AV, Roman YM, Pasupuleti V, Barboza JJ, White M. Hydroxychloroquine or Chloroquine for Treatment or Prophylaxis of COVID-19. Ann Intern Med [Internet]. 2020 [cited 2021 Feb 28];73(4):287-97. Available from: https://doi.org/10.7326/M20-2496

Wu TC, Sacilotto L, Darrieux FCC, Pisani CF, Melo SL, Hachul DT et al. QT interval control to prevent torsades de pointes during use of Hydroxychloroquine and/or Azithromycin in patients with COVID-19. Arq. bras. cardiol [Internet]. 2020 [cited 2021 Feb 28];114(6):1061-66. Available from: https://doi.org/10.36660/abc.20200389

Johnston C, Brown ER, Stewart J, Karita HCS, Kissinger PJ, Dwyer J et al. Hydroxychloroquine with or without azithromycin for treatment of early SARS-CoV-2 infection among high-risk outpatient adults: A randomized clinical trial. EClinicalMedicine [Internet]. 2021 [cited 2021 Feb 28];18(39). Available from: https://doi.org/10.1016/j.eclinm.2021.100773

Furtado RHM, Berwanger HA, Correa TD, Ferraz LR, Lapa MG et al. Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial. Lancet [Internet] 2020 [cited 2021 Feb 28];396: 959–67. Available from: https://doi.org/10.1016/ S0140-6736(20)31862-6

Sobrinho NP, Campos JF, Silva RC. Drug scheduling by nurses and drug interactions in patients with cardiovascular diseases. Rev. Bras. Enferm. [Internet]. 2020 [cited 2021 Feb 28];73(5). Available from: http://dx.doi.org/10.1590/0034-7167-2019-0307

Food and Drug Administration [Internet]. Information for Health Care Professionals. Ceftriaxone (marketed as Rocephin) [cited 2021 Feb 28]. Available from: http://www.fda.gov/cder/drug/InfoSheets/HCP/ceftriaxone.htm.

Bosetto A, Silva CM, Peder LD. Interações medicamentosas entre psicofármacos e a relação com perfil de prescritores e usuários. J. Health NPEPS [Internet].2020 [cited 2021 Feb 28];5(1):187-206. Available from: https://periodicos.unemat.br/index.php/jhnpeps/article/view/4104/3606

Santos JS, Giordani F, Rosa MLG. Interações medicamentosas potenciais em adultos e idosos na atenção primária. Ciênc. Saúde Colet [Internet]. 2019 [cited 2021 Feb 28];24 (11). Available from: https://doi.org/10.1590/1413-812320182411.04692018

Sobrinho NP, Campos JF, Silva RC. Drug scheduling by nurses and drug interactions in patients with cardiovascular diseases. Rev. Bras. Enferm. [Internet]. 2020 [cited 2021 Feb 28];73(5). Available from: https://doi.org/10.1590/0034-7167-2019-0307

Lima JVO, Cavalcante GL, Braga NSM, Silva AR, Silva TM, Gomes BP, et al. Potential risk of investigated drugs for the treatment of covid-19: drugs interactions. Rev. Prevenção de Infecção e Saúde [Internet]. 2020 [cited 2021 Feb 28];6:10829. Available from: https://revistas.ufpi.br/index.php/nupcis/article/view/10829/pdf

Souza AFR, Queiroz JC, Vieira NA, Solon LGS, Bezerra ELSF. Os erros de medicação e os fatores de risco associados a sua prescrição. Enferm. Foco [Internet]. 2019 [cited 2021 Jun 26];10(4):12-16. Available from: http://revista.cofen.gov.br/index.php/enfermagem/article/view/1900/598

Pinheiro TS, Mendonça ET, Siman AG, Carvalho CA, Zanelli FP, Amaro MOF. Administração de medicamentos em um serviço de emergência: ações realizadas e desafios para práticas seguras. Enferm. Foco [Internet]. 2020 [cited 2021 Jun 26];10(4):174-80. Available from: http://revista.cofen.gov.br/index.php/enfermagem/article/view/3172/968




DOI: https://doi.org/10.21675/2357-707X.2021.v12.n6.4914

Apontamentos

  • Não há apontamentos.


Licença Creative Commons
Esta obra está licenciada sob uma licença Creative Commons Atribuição 4.0 Internacional.

Eletrônico ISSN: 2357-707X

Impresso ISSN: 2177-4285

Licença Creative Commons
Este trabalho está licenciado com uma Licença Creative Commons - Atribuição 4.0 Internacional.